Skip to main content

Articles

Page 1 of 18

  1. Scholarship on how fentanyl affects the complexities of correctional settings is limited in Canada, as scholars have focused on the prevalence of opioid use and overdose in prisons, as well as community treatm...

    Authors: Rosemary Ricciardelli, Matthew S. Johnston and Gillian Foley
    Citation: Addiction Science & Clinical Practice 2024 19:70
    Content type: Research Published on:

  3. Incarceration provides an opportunity for health interventions, including opioid use disorder (OUD) treatment and prevention of opioid-related overdoses post-release. All FDA-approved forms of medication for O...

    Authors: Thomas J. Stopka, Rebecca Rottapel, Peter D. Friedmann, Ekaterina Pivovarova and Elizabeth A. Evans
    Citation: Addiction Science & Clinical Practice 2024 19:68
    Content type: Research Published on:

  4. Adolescents with chronic medical conditions (CMC) use alcohol and marijuana at levels equal to or even greater than their peers without CMC and are more likely to initiate substance use at 14 years or younger....

    Authors: Faith Summersett Williams, Robert Garofalo, Niranjan S. Karnik, Geri Donenberg, Hayley Centola, Sara Becker, Sarah Welch and Lisa Kuhns
    Citation: Addiction Science & Clinical Practice 2024 19:67
    Content type: Study Protocol Published on:

  5. Patients with chronic pain on opioids frequently experience loneliness, which is associated with poorer health outcomes and higher risk for opioid misuse and opioid use disorder. Given that almost half of opio...

    Authors: Sebastian T. Tong, Kris Pui Kwan Ma, Ajla Pleho, Brennan Keiser, Chialing Hsu, Dawn M. Ehde, Mary C. Curran, Judith I. Tsui, Patrick J. Raue and Kari A. Stephens
    Citation: Addiction Science & Clinical Practice 2024 19:66
    Content type: Study Protocol Published on:

  6. Hazardous alcohol use and alcohol use disorder (AUD) are highly prevalent among clients in mental health services, yet significant gaps remain in the adequate assessment of alcohol use and provision of appropr...

    Authors: Nathalie Kools, Andrea D. Rozema, Fieke A. E. van den Bulck, Rob H. L. M. Bovens, Jolanda J. P. Mathijssen and Dike van de Mheen
    Citation: Addiction Science & Clinical Practice 2024 19:65
    Content type: Research Published on:

  7. Unhealthy alcohol use represents a significant risk for morbidity and mortality among people living with HIV (PLWH), in part through its impact on HIV management. Chronic pain, a common comorbidity, exacerbate...

    Authors: Tibor P Palfai, Lauren B Bernier, Maya PL Kratzer, Kara M Magane, Sarah Fielman, John D Otis, Timothy C Heeren, Michael R Winter and Michael D Stein
    Citation: Addiction Science & Clinical Practice 2024 19:64
    Content type: Study Protocol Published on:

  8. Opioid related overdose morbidity and mortality continue to significantly impact rural communities. Nationwide, emergency departments (EDs) have seen an increase in opioid use disorder (OUD)-related visits com...

    Authors: Natasha Seliski, Troy Madsen, Savannah Eley, Jennifer Colosimo, Travis Engar, Adam Gordon, Christinna Barnett, Grace Humiston, Taylor Morsillo, Laura Stolebarger, Marcela C Smid and Gerald Cochran
    Citation: Addiction Science & Clinical Practice 2024 19:63
    Content type: Study Protocol Published on:

  9. Unhealthy alcohol use is a common public health problem in HIV care settings in Africa and it affects the HIV continuum of care. In Uganda and other low-income countries, HIV care providers are a key resource ...

    Authors: Raymond Felix Odokonyero, Noeline Nakasujja, Andrew Turiho, Naomi Sanyu, Winnie R. Muyindike, Denis Nansera, Fred Semitala, Moses R. Kamya, Anne R. Katahoire, Judith A. Hahn, Carol C. Camlin and Wilson W. Muhwezi
    Citation: Addiction Science & Clinical Practice 2024 19:62
    Content type: Research Published on:

  10. Diagnosis of alcohol use disorder (AUD) in primary care is critical for increasing access to alcohol treatment. However, AUD is underdiagnosed and may be inequitably diagnosed due to societal structures that d...

    Authors: Robert L. Ellis, Kevin A. Hallgren, Emily C. Williams, Joseph E. Glass, Isaac C. Rhew, Malia Oliver and Katharine A. Bradley
    Citation: Addiction Science & Clinical Practice 2024 19:61
    Content type: Research Published on:

  11. Many people with opioid use disorder who stand to benefit from buprenorphine treatment are unwilling to initiate it due to experience with or fear of both spontaneous and buprenorphine-precipitated opioid with...

    Authors: Lucinda A. Grande, Tom Hutch, Keira Jack, Wendy Mironov, Jessica Iwuoha, Martin Muy-Rivera, Jacob Grillo, Stephen A. Martin and Andrew Herring
    Citation: Addiction Science & Clinical Practice 2024 19:60
    Content type: Research Published on:

  13. Although clinical substance use disorder (SUD) care is multidisciplinary there are few opportunities to collaborate for quality improvement or systems change. In Oregon, the Project ECHO (Extension for Communi...

    Authors: NithyaPriya Ramalingam, Eowyn Rieke, Maggie McLain McDonnell, Emily Myers and Dan Hoover
    Citation: Addiction Science & Clinical Practice 2024 19:58
    Content type: Research Published on:

  14. Substance use disorders (SUDs) have been consistently shown to exhibit moderate intergenerational continuity (1–3). While much research has examined genetic and social influences on addiction, less attention h...

    Authors: Amanda Keller, Emily A. Bosk, Alicia Mendez, Brett Greenfield, Carolynn Flynn, Gina Everett (DelJones), Fabrys Julien and MacKenzie Michael
    Citation: Addiction Science & Clinical Practice 2024 19:57
    Content type: Research Published on:

  15. Despite continuing advancements in treatments for opioid use disorder (OUD), continued high rates of relapse indicate the need for more effective approaches, including novel pharmacological interventions. Gluc...

    Authors: Christopher S. Freet, Brianna Evans, Timothy R. Brick, Erin Deneke, Emily J. Wasserman, Sarah M. Ballard, Dean M. Stankoski, Lan Kong, Nazia Raja-Khan, Jennifer E. Nyland, Amy C. Arnold, Venkatesh Basappa Krishnamurthy, Julio Fernandez-Mendoza, H. Harrington Cleveland, Adam D. Scioli, Amanda Molchanow…
    Citation: Addiction Science & Clinical Practice 2024 19:56
    Content type: Study Protocol Published on:

  16. In the U.S. there are significant racial and gender disparities in the uptake of pre-exposure prophylaxis (PrEP). Black Americans represented 14% of PrEP users in 2022, but accounted for 42% of new HIV diagnos...

    Authors: Dawn Goddard-Eckrich, Tara McCrimmon, Keosha Bond, Mingway Chang, Timothy Hunt, Jennifer Hall, Mary Russo, Vineha Ramesh, Karen A. Johnson, Dget L. Downey, Elwin Wu, Nabila El-Bassel and Louisa Gilbert
    Citation: Addiction Science & Clinical Practice 2024 19:55
    Content type: Research Published on:

  18. Overdose deaths continue to rise within the United States, despite effective treatments such as buprenorphine and methadone for opioid use disorder (OUD). Mobile medical units with the ability to dispense bupr...

    Authors: Sarah E. Messmer, Abigail T. Elmes, Alexander F. Infante, Anna Patterson, Mackenzie Smith, Albert Leon Murphy, Antonio D. Jimenez, Stockton Mayer, Dennis P. Watson, Kevin Whitfield, Steven J. Fisher and Jennie B. Jarrett
    Citation: Addiction Science & Clinical Practice 2024 19:53
    Content type: Research Published on:

  19. Cigarette smoking remains a leading cause of preventable illness and death, underscoring the need for effective evidence-based smoking cessation interventions. Nuumi, a novel smoking cessation program integrat...

    Authors: Helen Schiek, Tobias Esch, Maren M. Michaelsen and Cosima Hoetger
    Citation: Addiction Science & Clinical Practice 2024 19:52
    Content type: Study Protocol Published on:

  20. Clinic-based interventions are needed to promote successful direct acting antiviral (DAA) treatment for chronic hepatitis C virus (HCV) infection in patients with substance use disorders (SUDs) among rural Vet...

    Authors: Mary Jane Burton, Andrew C. Voluse and Amee B. Patel
    Citation: Addiction Science & Clinical Practice 2024 19:51
    Content type: Research Published on:

  21. Buprenorphine is an effective and safe treatment for opioid use disorder, but the requirement for moderate opioid withdrawal symptoms to emerge prior to initiation is a significant treatment barrier.

    Authors: Pouya Azar, Hannah Schneiderman, Henry Barron, James S. H. Wong, Maximilian Meyer, Dayyon Newman-Azar, Matin Narimani, Martha J. Ignaszewski, Nickie Mathew, Rodney Mullen, Reinhard M. Krausz and Anil R. Maharaj
    Citation: Addiction Science & Clinical Practice 2024 19:50
    Content type: Case Study Published on:

  22. The 15-method is a targeted screening and treatment approach for alcohol problems in primary care. The 15-method used in primary care has proven as effective as specialized treatment for mild to moderate alcoh...

    Authors: Peter Næsborg Schøler, Kristina Hasselbalch Volke, Sven Andréasson, Sanne Rasmussen, Jens Søndergaard and Anette Søgaard Nielsen
    Citation: Addiction Science & Clinical Practice 2024 19:49
    Content type: Study Protocol Published on:

  23. Regulations put in place to protect the privacy of individuals receiving substance use disorder (SUD) treatment have resulted in an unintended consequence of siloed SUD treatment and referral information outsi...

    Authors: Alexandra R. Tillman, Emily Bacon, Brooke Bender, Dean McEwen, Joshua Blum, Matthew Hoag, Kenneth A. Scott, Rachel Everhart, Rebecca Hanratty, Laura J. Podewils, Carolina Close, John Mills and Arthur J. Davidson
    Citation: Addiction Science & Clinical Practice 2024 19:48
    Content type: Research Published on:

  24. Women who engage in sex work and use drugs (WSWUD) experience disproportionate HIV risks. Substance use treatment bridge clinics offer an opportunity to increase HIV pre-exposure prophylaxis (PrEP) delivery to...

    Authors: Miriam TH Harris, Emma Weinberger, Christine O’Brien, Mary Althoff, Samantha Paltrow-Krulwich, Jessica L. Taylor, Abigail Judge, Jeffrey H. Samet, Alexander Y. Walley and Christine M. Gunn
    Citation: Addiction Science & Clinical Practice 2024 19:47
    Content type: Research Published on:

  25. Implementation of pre-exposure prophylaxis (PrEP) to prevent HIV transmission is suboptimal in the United States, particularly among people who use drugs (PWUD). PrEP research among PWUD is scarce, and the fac...

    Authors: James L. Merle, Juan P. Zapata, Artur Quieroz, Alithia Zamantakis, Olutobi Sanuade, Brian Mustanski and Justin D. Smith
    Citation: Addiction Science & Clinical Practice 2024 19:46
    Content type: Review Published on:

  26. Supervised injectable opioid treatment (SIOT) is a promising alternative for people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral opioid substitution treatment. Yet, SIOT...

    Authors: Zoe Friedmann, Hans-Tilmann Kinkel, Claudia Kühner, Andreas Zsolnai, Annette Binder and Inge Mick
    Citation: Addiction Science & Clinical Practice 2024 19:45
    Content type: Research Published on:

  27. Norway has a growing proportion of ageing opioid agonist treatment (OAT) patients, with 42% of the 8300 Norwegian OAT patients aged over 50 in 2022. This study aims to explore practitioners’ views and experien...

    Authors: John Todd-Kvam and Thomas Clausen
    Citation: Addiction Science & Clinical Practice 2024 19:44
    Content type: Research Published on:

  28. Delivering methadone treatment in community health facilities by primary care providers is a task-shifting strategy to expand access to drug use treatment, especially in rural mountainous areas. This study aim...

    Authors: Bich Diep Nguyen, Li Li, Chunqing Lin, Thu Trang Nguyen, Steven Shoptaw and Minh Giang Le
    Citation: Addiction Science & Clinical Practice 2024 19:43
    Content type: Research Published on:

  29. To assess the extent of Coronavirus-related disruption to health and social care treatment and social interactions among people with lived or living experience of substance use in Scotland, and explore potenti...

    Authors: Mark McCann, Federica Bianchi, Srebrenka Letina, Samantha Stewart, Katy McLeod and Mark Tranmer
    Citation: Addiction Science & Clinical Practice 2024 19:42
    Content type: Research Published on:

  30. Alcohol-attributable medical disorders are prevalent among individuals with alcohol use disorder (AUD). However, there is a lack of research on prescriptions of pharmacological treatment for AUD in those with ...

    Authors: Anastasia Månsson, Anna-Karin Danielsson, Hugo Sjöqvist, Toivo Glatz, Andreas Lundin and Sara Wallhed Finn
    Citation: Addiction Science & Clinical Practice 2024 19:41
    Content type: Research Published on:

  31. People with substance use disorders (SUDs) have restricted engagement with health-care facilities and describe repeated experiences of stigma, discrimination, and mistreatment when receiving care at health-car...

    Authors: Maryam Khazaee-Pool, Seyed Abolhassan Naghibi, Tahereh Pashaei and Koen Ponnet
    Citation: Addiction Science & Clinical Practice 2024 19:40
    Content type: Study Protocol Published on:

  32. Injection Drug use is associated with increased HIV risk behaviour that may result in the transmission of HIV and poor access to HIV prevention and treatment. In 2020, Uganda introduced the ‘medication for opi...

    Authors: Peter Mudiope, Brian Byamah Mutamba, Liz Komuhangi, Joan Nangendo, Stella Alamo, Bradley Mathers, Fredrick Makumbi and Rhoda Wanyenze
    Citation: Addiction Science & Clinical Practice 2024 19:39
    Content type: Research Published on:

  33. Children at risk of substance use disorders (SUD) should be detected using brief structured tools for early intervention. This study sought to translate and adapt the Car, Relax, Alone, Forget, Family/Friends,...

    Authors: Joyce Sserunjogi Nalugya, Ingunn Marie Stadskleiv Engebretsen, Noeline Nakasujja, Grace Ndeezi, Juliet N. Babirye, Victoria Bakken, Ane-Marthe Solheim Skar, James K. Tumwine and Norbert Skokauskas
    Citation: Addiction Science & Clinical Practice 2024 19:38
    Content type: Research Published on:

  34. Knowledge of co-occurring mental disorders (termed ‘dual diagnosis’) among patients receiving opioid agonist treatment (OAT) is scarce. This study aimed (1) to estimate the prevalence and structure of dual dia...

    Authors: Gabriela Rolová, Svetlana Skurtveit, Roman Gabrhelík, Viktor Mravčík and Ingvild Odsbu
    Citation: Addiction Science & Clinical Practice 2024 19:37
    Content type: Research Published on:

  35. Digital technologies have positively impacted the availability and usability of clinical algorithms through the advancement in mobile health. Therefore, this study aimed to determine if a web-based algorithm d...

    Authors: Irene Tamí-Maury, Samuel Tundealao, Valeri Noé-Díaz, Esperanza Garcia, Vilma Diaz, Jennie Meier, Mira Dani and Tatiana Vidaurre
    Citation: Addiction Science & Clinical Practice 2024 19:36
    Content type: Research Published on:

  36. As the return to alcohol use in individuals with alcohol use disorder (AUD) is common during treatment and recovery, it is important that abstinence motivation is maintained after such critical incidences. Our...

    Authors: Catharina Lang, Kiona K. Weisel, Sebastian Saur, Lukas M. Fuhrmann, Antonie Schoenleber, Daniela Reichl, Niklas Enewoldsen, Sabine Steins-Loeber and Matthias Berking
    Citation: Addiction Science & Clinical Practice 2024 19:35
    Content type: Research Published on:

  38. Individuals with substance use disorders (SUDs) frequently use acute hospital services. The Navigation Services to Avoid Rehospitalization (NavSTAR) trial found that a patient navigation intervention for hospi...

    Authors: Courtney D. Nordeck, Sharon M. Kelly, Robert P. Schwartz, Shannon G. Mitchell, Christopher Welsh, Kevin E. O’Grady and Jan Gryczynski
    Citation: Addiction Science & Clinical Practice 2024 19:33
    Content type: Research Published on:

  39. Health care providers are a key source of reports of infants to child welfare related to birthing people’s substance use. Many of these reports are overreports, or reports that exceed what is legally mandated,...

    Authors: Sarah C. M. Roberts, Kimá Joy Taylor, Karen Alexander, Daisy Goodman, Noelle Martinez and Mishka Terplan
    Citation: Addiction Science & Clinical Practice 2024 19:32
    Content type: Research Published on:

  40. Hospitalization presents an opportunity to begin people with opioid use disorder (OUD) on medications for opioid use disorder (MOUD) and link them to care after discharge; regrettably, people admitted to the h...

    Authors: Sandra K. Evans, Allison J. Ober, Ariella R. Korn, Alex Peltz, Peter D. Friedmann, Kimberly Page, Cristina Murray-Krezan, Sergio Huerta, Stephen J. Ryzewicz, Lina Tarhuni, Teryl K. Nuckols, Katherine E. Watkins and Itai Danovitch
    Citation: Addiction Science & Clinical Practice 2024 19:31
    Content type: Research Published on:

  41. Alcohol misuse is common and causes substantial harm. Internet-delivered cognitive behaviour therapy (ICBT) is effective in reducing alcohol misuse; however, the literature investigating how treatment outcomes...

    Authors: Ram P. Sapkota, Tristen Lozinski, Andrew Wilhems, Marcie Nugent, Michael P. Schaub, Matthew T. Keough, Christopher Sundström and Heather D. Hadjistavropoulos
    Citation: Addiction Science & Clinical Practice 2024 19:30
    Content type: Research Published on:

  42. Hospitalizations involving opioid use disorder (OUD) are increasing. Medications for opioid use disorder (MOUD) reduce mortality and acute care utilization. Hospitalization is a reachable moment for initiating...

    Authors: Gavin Bart, P. Todd Korthuis, Julie M. Donohue, Hildi J. Hagedorn, Dave H. Gustafson, Angela R. Bazzi, Eva Enns, Jennifer McNeely, Udi E. Ghitza, Kara M. Magane, Paulette Baukol, Ashley Vena, Jacklyn Harris, Delia Voronca and Richard Saitz
    Citation: Addiction Science & Clinical Practice 2024 19:29
    Content type: Study Protocol Published on:

  43. Substance use disorder (SUD) is associated with executive function (EF) deficits and sensory modulation dysfunction (SMD). Yet, these deficits are not addressed therapeutically. This study aims to examine the ...

    Authors: Naama Assayag, Tami Bar-Shalita and Debbie Rand
    Citation: Addiction Science & Clinical Practice 2024 19:28
    Content type: Study Protocol Published on:

  44. Pharmacy-based screening and brief interventions (SBI) offer opportunities to identify opioid misuse and opioid safety risks and provide brief interventions that do not overly burden pharmacists. Currently, su...

    Authors: Deepika Rao, James H. Ford and Olayinka O. Shiyanbola
    Citation: Addiction Science & Clinical Practice 2024 19:27
    Content type: Research Published on:

  45. Emergency departments (ED) are incorporating Peer Support Specialists (PSSs) to help with patient care for substance use disorders (SUDs). Despite rapid growth in this area, little is published regarding workf...

    Authors: Lindsey K Jennings, Laura Lander, Tricia Lawdahl, Erin A. McClure, Angela Moreland, Jenna L. McCauley, Louise Haynes, Timothy Matheson, Richard Jones, Thomas E. Robey, Sarah Kawasaki, Phillip Moschella, Amer Raheemullah, Suzette Miller, Gina Gregovich, Deborah Waltman…
    Citation: Addiction Science & Clinical Practice 2024 19:26
    Content type: Research Published on:

  46. Long-acting injectable buprenorphine (LAIB) formulations are a novel treatment approach in opioid agonist treatment (OAT), which provide patients with a steady dose administered weekly or monthly and thus redu...

    Authors: Johan Nordgren, Bodil Monwell, Björn Johnson, Nina Veetnisha Gunnarsson and Andrea Johansson Capusan
    Citation: Addiction Science & Clinical Practice 2024 19:25
    Content type: Research Published on:

  47. The Cannabis Abuse Screening Test (CAST) is a widely used screening tool for identifying patterns of cannabis use that have negative health or social consequences for both the user and others involved. This br...

    Authors: Hicham El Malki, Salma Ghofrane Moutawakkil, Abdelfettah El-Ammari, Mohammed El Amine Ragala, Jaouad El Hilaly, Samir El Gnaoui, Fatima El Houari, Karima El Rhazi and Btissame Zarrouq
    Citation: Addiction Science & Clinical Practice 2024 19:24
    Content type: Research Published on:

  48. Communities That HEAL (CTH) is a novel, data-driven community-engaged intervention designed to reduce opioid overdose deaths by increasing community engagement, adoption of an integrated set of evidence-based ...

    Authors: Iván D. Montoya, Colleen Watson, Arnie Aldridge, Danielle Ryan, Sean M. Murphy, Brenda Amuchi, Kathryn E. McCollister, Bruce R. Schackman, Joshua L. Bush, Drew Speer, Kristin Harlow, Stephen Orme, Gary A. Zarkin, Mathieu Castry, Eric E. Seiber, Joshua A. Barocas…
    Citation: Addiction Science & Clinical Practice 2024 19:23
    Content type: Research Published on:

  49. Hospitalization is a “reachable moment” for people who inject drugs (PWID), but preventive care including HIV testing, prevention and treatment is rarely offered within inpatient settings.

    Authors: William Bradford, Hana Akselrod, John Bassler, Kelly W. Gagnon, Greer Burkholder, Joseph Edward Carpenter, Alaina Steck, Jillian Catalanotti, Irene Kuo, Keanan McGonigle, William Mai, Melissa Notis, Christopher Brokus, Sarah Kattakuzhy, Elana Rosenthal and Ellen F. Eaton
    Citation: Addiction Science & Clinical Practice 2024 19:22
    Content type: Letter to the Editor Published on:

  50. People who inject drugs (PWID) remain a high priority population under the federal Ending the HIV Epidemic initiative with 11% of new HIV infections attributable to injection drug use. There is a critical need...

    Authors: Tyler S. Bartholomew, Marina Plesons, David P. Serota, Elizabeth Alonso, Lisa R. Metsch, Daniel J. Feaster, Jessica Ucha, Edward Suarez Jr., David W. Forrest, Teresa A. Chueng, Katrina Ciraldo, Jimmie Brooks, Justin D. Smith, Joshua A. Barocas and Hansel E. Tookes
    Citation: Addiction Science & Clinical Practice 2024 19:21
    Content type: Study Protocol Published on:
Submit manuscript
  • New Content Item

Follow

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.7
    5-year Journal Impact Factor: 4.2
    Source Normalized Impact per Paper (SNIP): 1.062
    SCImago Journal Rank (SJR): 1.307

    Speed 2023
    Submission to first editorial decision (median days): 28
    Submission to acceptance (median days): 202

    Usage 2023
    Downloads: 755,413
    Altmetric mentions: 622

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.

Addiction Science & Clinical Practice

ISSN: 1940-0640